Seeking Alpha

Michael Mahoney officially assumes the title of CEO at Boston Scientific (BSX) today after...

Michael Mahoney officially assumes the title of CEO at Boston Scientific (BSX) today after serving for a year as president following his departure from Johnson & Johnson, which basically allowed him to get round a non-compete agreement. Mahoney succeeds interim CEO William Kucheman.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs